Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.

Diabetes, obesity & metabolism(2023)

Cited 1|Views9
No score
Abstract
These results emphasize a critical role of canagliflozin in kidney protection across a broad spectrum of participants with type 2 diabetes with varying levels of kidney function.
More
Translated text
Key words
canagliflozin, cardiovascular disease, diabetic nephropathy, SGLT2 inhibitors, type 2 diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined